| # | Filing Date | Period End Date | Type | Report Link | 
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	
																	Deutsche Bank analyst Niall Alexander downgrades Alvotech (NASDAQ:ALVO) from Buy to Hold and lowers the price target from $1...
																	
																	Alvotech shares decline after the FDA issues a complete response letter for its Simponi biosimilar, leading to a lower 2025 rev...